Search
Close this search box.

When to Suggest SRT Therapy Over Mohs Surgery

For decades, Mohs surgery has been considered the “gold standard” for the treatment of basal cell carcinomas and squamous cell carcinomas, even for cases where cosmetically important features of the face like the eyes, nose, lips, ears, and scalp are the area being treated. As the incidence of basal cell carcinoma and squamous cell carcinoma […]

How to Perform a Skin Cancer Self-Exam

According to the Skin Cancer Foundation, adults should thoroughly examine their skin on a monthly basis for signs of skin cancer, as well as visit a dermatologist for an annual professional skin exam. If you’ve never conducted a skin cancer self-exam before, now is the best time to start. Here are some tips to help […]

Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018

BOCA RATON, Fla., Jan. 25, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, February 1, 2018 at 4:30 p.m. ET to discuss the financial results for […]

Global Keloid Treatment Market to Reach US $4.4 Billion by 2027

The expected increase of keloid scar occurrences, the shift from Mohs surgery as well as developments in advanced cryosurgery and radiation therapy devices will bring about an increase in the demand for keloid treatment. Read more: Global Keloid Treatment Market to Reach US $4.4 Billion by 2027